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Abstract
BACKGROUND: Management of bone periodontal defects, destruction, and loss of the alveolar bone is considered 
a challenge for modern periodontal regeneration and implant dentistry. Numerous of biomaterials are being used in 
periodontal regenerative treatment.
AIM: This study aims to know the characteristics of biomaterials and their efficiency in periodontal surgical treatment 
as regenerative therapy.
METHODS: A systematic review of the literature considering reviews, clinical studies, original papers, and articles 
from electronic data has been used.
RESULTS: Different biomaterials such as Straumann® Emdogain®, Geistlich Bio-Oss®, MIS 4MATRIX – Bone Graft, 
Platelet-rich fibrin (PRF), Mis Bone-4MATRIX, and PRF are being used for periodontal regeneration treatment, 
hence revealing more effective outcomes when combined. PRP together with conventional grafting procedures may 
be a beneficial treatment approach, guided tissue regeneration with bioabsorbable membranes in combination with 
Bio-Oss are stable on a long-term basis.
CONCLUSION: Biomaterials being used in periodontal surgical treatment have the different regenerative ability. The 
combined use of biomaterials might result in a better clinical outcome. There are also a number of other biomaterials 
used to treat periodontal regeneration, but generally all have the same ability and the same molecular structure as 
highlighted in this literature review.
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Introduction
Periodontal disease is not new. Archeological 
investigations have revealed evidence of alveolar 
bone loss affecting human remains dating from around 
700,000 years ago [1].
The main chronic infective disease of the gums 
that affects around 10–30% of the adult population is 
periodontitis.
Bacteria, present in the dental plaque, are 
capable of inducing an inflammatory response of 
the periodontal tissues. In susceptible individuals, 
this chronic inflammation will induce a breakdown of 
the periodontal ligament (PDL) and the surrounding 
alveolar bone resulting in the formation of periodontal 
pockets around the roots, thus causing periodontitis [2].
Periodontitis, the main cause of tooth loss 
in adults, is characterized by the bacterially induced 
inflammation, which frequently results in the formation 
of intrabony defects. It affects the supporting structures 
of the teeth, including the jawbone, PDL, and 
cementum. Apart of functional and esthetic problems 
in the oral cavity, periodontitis is being associated 
with systemic diseases, such as diabetes, preterm 
birth, cardiovascular disease, stroke, and pulmonary 
disease as well [3]. The ultimate involves the formation 
of new cementum on the tooth root, along with new 
periodontal attachment between newly formed bone 
and cementum [4].
Periodontitis is a disease characterized by 
pathological processes that involve all structures 
around the tooth (periodontium, cement, alveolar bone, 
and gingiva). During the development of the disease, 
complex and irreversible mechanisms induce bone 
destruction and resorption, which definitely leads to 
tooth loss [5]. It is commonly known that periodontal 
disease results in different types of alveolar bone 
defects. One of them is periodontal pockets which 
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represent the most important clinical sign of periodontal 
disease, thus are considered basic pathognomonic 
features of this very frequent disease present in the 
population [6], [7].
History
Descriptions of conditions that we would now 
refer to as periodontitis can be found in a number of 
ancient textbooks, papyruses, and manuscripts, such as 
Al-Tasrif, the medical encyclopedia written by Albucasis 
(936–1013) in Moorish Spain. In addition to the clinical 
features of periodontitis, some of these early authors 
also described treatment strategies for this condition.
If we spend a moment to imagine the likely 
oral health status of many of the people living in the 
Мiddle Ages, in the time of Albucasis, for example, we 
would probably conjure up images of abundant calculus 
deposits, inflamed gingival tissues, gingival bleeding, and 
halitosis. In the United States of America, Riggs (1810–
1885) regarded calculus as the cause of periodontal 
disease, thus treated the condition by meticulous removal 
of calculus from pockets, “curettage” of the soft tissues and 
oral hygiene instruction. Furthermore, the etiological role 
of plaque in the development of gingival inflammation was 
confirmed in experimental studies on gingivitis conducted 
in the 1960s: Upon cessation of oral hygiene practices 
over periods of 3–4 weeks, plaque accumulation resulted 
in gingivitis, which was reversed following plaque removal 
and resumption of normal oral hygiene [8].
Studies on the natural history of periodontitis 
performed in Sri Lankan tea plantation workers 
between 1970 and 1985 provided basic information on 
oral conditions unaffected by any dental monitoring, 
prophylaxis or therapy and in the absence of any 
professionally recommended or supervised oral 
hygiene practices over a period of 15 years [9]. A 
subsequent examination of this distinct Cohort in 1990 
confirmed the ongoing progression of periodontitis 
and the influence of tobacco consumption or betel nut 
chewing on attachment loss and periodontitis-related 
tooth loss over 20 years [10]. While clinical data from 
these studies generally suggested an overall increase 
in both prevalence and severity of the disease with 
advancing age, different disease progression rates 
within the subjects were recognized. Consequently, 
three subgroups of subjects were identified with various 
periodontal disease progression rates: (1) Rapid 
progression, in approximately 8% of the subjects, 
(2) moderate progression, in approximately 81% of the 
subjects, and (3) minimal progression, in approximately 
11% of the subjects. Over a period of 15 years, the 
annual rates of clinical attachment loss in these three 
subgroups were up to 1.0 mm in the first group, 0.5 mm 
in the second group, and 0.1 mm in the third group [11].
Already some 4000 years ago, the ancient 
Egyptians and Chinese described periodontal diseases 
as inflammatory conditions, and Hippocrates (460-
335B.C.) discussed the etiology and pathogenesis of 
different forms, including the situation when “the gums 
were bleeding or rotten” [12].
The early Hebrews Jews, the Romans, and 
later the Arabs of the middle ages contributed in various 
ways to the description and treatment of these diseases. 
However, it is probably fair to consider the 1746 
publication of Pierre Fauchard [13] and Le Chirurgien 
Dentiste, as providing the first discussion of periodontal 
pathology and therapy with some modicum of 
intellectuality and usefulness. Fauchard recommended 
thorough scaling of the teeth with special instruments 
to remove calculus. He also prescribed mouthwashes, 
dentifrices, and the splinting of loose teeth.
The early English contribution to the 
understanding and management of periodontal diseases 
was made by John Hunter, a physiologist and surgeon of 
broad intellectual and scientific interests, widely known 
for his 1771 work on the natural history of the human 
teeth [14]. In another major work from 1802, a practical 
treatise on the diseases of the teeth, Hunter proposed a 
classification of the periodontal diseases that identified 
inflammatory processes in the gingiva as important 
factors in the resorption of the alveolar bone [15].
Etiology
The term “endotoxin” was first introduced 
to denote toxic substances within bacterial cells 
that were released upon the death of the bacteria. 
Today, the term is used synonymously with the term 
“lipopolysaccharide,” which is a component of the outer 
cell wall of Gram-negative bacteria. It was hypothesized 
that this endotoxin would limit the effectiveness of 
periodontal therapy because even if plaque and calculus 
were removed from the root surface, the endotoxin still 
presents in the cementum would continue to irritate 
the tissues and thus compromise healing following 
treatment. This presumption led to the preeminence of 
the treatment concept known as “root planning,” often 
combined as a treatment strategy with scaling, and 
abbreviated as “scaling and root planning.”
Periodontal Regeneration and 
Biomaterials
Management of bone periodontal defects, 
destruction, and loss of the alveolar bone in the upper 
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or lower jaw is considered a challenge for modern 
periodontal regeneration and implant dentistry [16].
There are numerous of biomaterials that are 
being used in the regenerative therapy of periodontal 
disease such as Straumann® Emdogain®, Geistlich Bio-
Oss® made from the mineral part of bovine bone, MIS 
4MATRIX – Bone Graft, and Platelet-rich fibrin (PRF).
The first step in the periodontal treatment 
procedures is the removal of supra and subgingival 
concernments deposits but in parallel with that an 
individual approach in educating and motivating 
patients to maintain oral hygiene, and then processing 
the hard and soft wall of the periodontal pocket, removal 
of granulation, ulceration and proliferation from the soft 
wall, polishing the root surface, and, where necessary, 
planning, and performing periodontal surgery. After 
the applied therapeutic procedures, it is possible 
to eliminate or reduce the depth of the periodontal 
pockets and to create a new junction epithelium [17]. 
The ultimate goal of any periodontal therapy is not only 
to prevent the progression of periodontal disease but 
also to regenerate the architecture and function of the 
periodontal complex, which involves the formation of a 
new cement of the root of the tooth, as well as a new 
epithelial attachment [4], and motivating patients to 
maintain proper oral hygiene.
Number of therapeutic modalities, nonsurgical, 
and surgical procedures, and aim to prevent progressive 
attachment loss, reduce probing pocket depths (PPD) 
and control both systemic and local risk factors 
associated with periodontal disease. In this literature 
review, we are going to highlight some of biomaterials 
and procedures which involve directly in periodontal.
One of the most important interventions 
recommended in this domain is guided tissue 
regeneration (GTR/guided bone regeneration). It is a 
surgical procedure that is aimed at restoring periodontal 
tissues. In general, the goal of periodontal therapy is the 
elimination of deep periodontal pockets. The treatment 
of periodontitis is cause-related, so it should be known 
the cause of periodontitis to treat and fight against 
that. The first step is to mechanically clean periodontal 
pockets from bacteria (debridement). The crucial role for 
the success of the therapy is the patient’s home plaque 
control since pockets can be recolonized by bacteria in a 
few weeks. In the presence of deep pockets, surgery may 
also be indicated to get access to the deepest portions 
of the pockets to properly clean them and to reduce the 
depth of the pockets. The goal of this treatment approach 
is healing by repair without the formation of new 
periodontal attachment [18]. This can be done by different 
types of bone grafts, membranes, growth factors, etc. 
Using the grafts, we try to help the regeneration of lost 
periodontal tissue. There are many original papers which 
are talking about regenerative therapy in the treatment of 
periodontal intrabony defects. The main parameters that 
we check after regenerative therapy are plaque index, 
papillary bleeding index, and PPD. The ideal treatment 
would be to recover the periodontal tissues that have 
been lost (periodontal tissue regeneration). Several 
surgical techniques have been developed in the attempt 
to regenerate periodontal tissues, including GTR, bone 
grafting (BG), and the use of the enamel matrix derivative 
(EMD). All these treatments have been shown to have 
the potential to regenerate at least some periodontal 
attachment in humans [19]. Its seen that the effects of 
Enamel Matrix Derivative and Natural Bone Mineral with 
Platelet-Rich Plasma on the Healing of Intrabony Defects 
Treated was treated very good by Döri et al. where the use 
of PRP does not appear to improve the results obtained 
with EMD+NBM (Table 1) [20]. To compare mandibular 
bone regeneration by applying autologous bone, platelet-
rich plasma and two biomaterials (synthetic calcium 
hydroxyapatite, and demineralized bone matrix), and 
thus establish the potential benefits of these biomaterials 
in the regeneration of post extraction alveolar bone the 
faster bone formation occurred in the groups where are 
used autologous bone and demineralized bone matrix, 
respectively (Table 1) [21]. 
Periodontal regeneration mediated by EMD 
is based on a different concept. The enamel matrix is 
composed of a number of proteins, 90% of which is 
amelogenin. The only commercially available product 
using EMD is called Emdogain and is produced by 
Biora (Malmö, Sweeden). One year after treatment 
of periodontal resorption by EMD showed statistically 
significant improvements in probing attachment levels 
(1.3 mm) and PPD reduction (1 mm) in comparison with 
flap surgery. However, the actual clinical advantages 
might be questioned since there is not yet evidence 
that more teeth can be saved using EMD. No evidence 
of major differences between EMD and GTR could be 
found with the expectation slightly more PPD reduction 
(0.6 mm) due to increased gingival recession (REC) 
0.5 mm in GTR treated sites. On the other hand, EMD 
seems simpler to use, may not need antibiotic coverage 
and does not need a second surgical intervention (if 
compared with non-resorptive barriers). In addition, 
no post-operative infections or adverse events were 
observed with EMD versus two cases of infection (not 
statistically significant) in the GTR group.
Some clinical study recommends the use of 
Bio-Oss deproteinized bovine bone mineral alone or in 
combination with Emdogain for surgical regenerative 
procedure in human periodontal intrabony defects. 
In the study by Koop et al. [22], the use of Bio-Oss 
combined with EMD-Emdogain as a biologic factor in 
consistence with the regenerative surgical procedure 
is recommended for the periodontal healing. The 
conclusion of this study was that in the treatment of 
intrabony defects, the use of EMD is superior to control 
treatments but as effective as resorbable membranes. 
The additional use of EMD with a coronally advanced 
flap for REC coverage will give superior results 
compared with control but is as effective as a connective 
tissue graft. The use of EMD in furcations will give more 
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Table 1: Studies of different biomaterials used for periodontal regeneration
Authors Application of Year publication Follow-up Main results Reference
Koop et al. Enamel Matrix Derivative 2012 12 months Effective in reduction of horizontal furcation [22]
Najeeb et al. PRF with open flap debridement 2017 12 months Very god outcomes in regenerative therapy [23]
Hou et al. PRP in treatment of intrabony defects 2016 6 months PRP together with conventional grafting procedures may 
be a beneficial treatment approach
[24]
Stavropoulos and Karring GTR with bioabsorbable membranes+DBB (Bio-Oss) 2005 5 years GTR with bioabsorbable membranes in combination with 
Bio-Oss is basically stable on a long-term basis
[25]
Agarwal et al. PRF+DFDBA 2016 12 months PRF+DFDBA more effective than DFDB with saline [26]
Pradeep et al. Platelet Rich Fibrin with 1% Metformin 2015 9 months PRF +1% MF group showed better results in clinical 
parameters and radiograph defect depth reduction 
compare to MF, PRF, or OFD alone
[27]
Shah et al. PRF+DFDBA 2012 12 months PRF shows comparable results to DFDBA in terms of 
clinical parameters
[28]
Lekovic et al. PRF and BPBM 2012 6 months Both PRF and PRF-BPBM groups showed significant 
pocket depth reduction at 6 months compared with 
baseline
[29]
Panda et al. Autologous platelet concentrates (APCs) 2016 9 months APCs in surgical treatment of intrabony defects have been 
increasing in recent years
[30]
Esposito et al. Emdogain 2009 Very good regenerative effect on bone healing [2] 
Galgut Biodegradable oxidized cellulose and hydroxyapatite 1990 8 weeks Guided tissue regeneration  techniques have been shown 
to enhance new attachment formation with minimal post-
operative recession
[31] 
Kökdere et al. PRF and PRF-mixed particulate autogenous bone 
graft
2015 2 months PRF increase new bone formation and has a positive 
effect on early bone healing 
[32]
Albanese et al. PRP from the wound healing to bone regeneration 2013 12 months Positively influence bone regeneration [33]
Célio-Mariano et al. Autologous platelet rich plasma after impacted third 
molar mandible surgery
2012 6 months Autologous PRP was found to accelerate alveolar bone 
regeneration, and men presented better repair after tooth 
extraction
[34]
Dohan et al. Platelet-rich fibrin (PRF 2006 6 months The biologic activity of the fibrin molecule is enough in 
itself to account for the significant cicatricle capacity of 
the PRF
[35]
Arenaz-Búa et al. Platelet-rich plasma, hydroxyapatite, demineralized 
bone matrix, and autologous bone 
2009 10 days The faster bone formation occurred in the groups where 
we used autologous bone and demineralized bone matrix, 
respectively
[21]
Kobayashi et al. Comparative release of growth factors from PRP, 
PRF, and advanced-PRF
2016 10 days PRP can be recommended for fast delivery of growth 
factors whereas A-PRF is better-suited for long-term 
release.
[36] 
Needleman et al. Guided tissue regeneration for periodontal infra-bony 
defects
2012 12 months GTR has a greater effect on probing measures of 
periodontal treatment than open flap debridement
[37]
Sebben et al. Platelet-rich plasma alone and in combination on with 
alpha-tricalcium phosphate cement
2012 8 weeks The data from this study suggest that treatment with 
α-TCP cement combined with PRP does not show any 
significant difference in comparison with PRP alone
[38]
Ozdemir and Okte Beta-tricalcium phosphate alone and in combination 
with platelet-rich plasma
2011 6 months After 6 months, both treatment modalities showed 
statistically significant clinical and radiographically 
improvements
[39]
Döri et al. Platele-trich plasma enamel matrix derivative and 
natural bone mineral
2013 5 years (1) The clinical outcomes obtained with both treatments 
can be maintained up to a period of 5 years and (2) 
the use of PRP does not appear to improve the results 
obtained with EMD+NBM
[20]
reduction in horizontal furcation defect depth compared 
with resorbable membranes.
The results of the study of Gojkov-Vukelic 
et al. [40] using Maxresorb (Botiss dental) as 
regenerative grafts in periodontal pockets showed a 
significant reduction in probing depth for both groups 
of patients (treated by open flap surgery and treated 
by open flap surgery in addition with Maxresorb), 1 
and 6 months after the performed surgical therapy. 
By comparing the results between the groups, they 
did not get significantly better results for Group 2, 
where Maxresorb was used as bone replacement. 
This research is the opposite with findings of the study 
by Gokhale [41], whose results showed significant 
improvement for clinical parameters at sites treated 
with Bio-Oss compared to control sites.
In the research by Shivjot Chhina comparing of 
treatment results using standard flap surgery and flap 
surgery with the addition of free gingival graft revealed 
better treatment outcomes in the group with free gingival 
graft [42]. The conclusion was that the treatment of 
supracrestal defects with a combination of open flap 
debridement (OFD) and SECTG led to significantly 
better clinical results compared to OFD alone.
Results from meta-analysis indicated that the 
treatment of periodontal bone defects with intraoral 
BGs in periodontal regeneration is not always 
predictable [43]. The literature review of GTR in a lot 
of case studies has shown that this procedure is more 
effective than OFD, with an additional gain in clinical 
attachment level of 1.2 mm [37].
Platelet-rich plasma (PRP) is autologous plasma 
which has been enriched with platelets and leukocytes 
in addition to jellifying agents, growth factors, cytokines, 
bovine thrombin, and anticoagulants [44], [45]. One 
of the drawbacks of PRP is the fact that it has liquid 
nature and therefore required its combination with other 
biomaterials, including bone grafts derived from human 
cadavers (allografts) or animal products (xenografts). 
Data points out to the quick “burst” release of growth 
factors from PRP [46].
In many reviews, we noticed that PRP has 
been used as a regenerative substituent to promote 
wound healing and tissue regeneration [47]. Comparing 
with PRF, PRP has some limitations because the 
growth factors are released for a very short period of 
time, also the bovine clotting factors may react with 
human clotting factors to give rise to bleeding. There 
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is a reason that PRF as a second-generation platelet 
derivative, called PRF has been used in regenerative 
medicine and dentistry [35], [48], [49]. One of the main 
differences between PRF and previously utilized PRP is 
the incorporation of leukocytes in PRF. Several studies 
have shown their key importance during anti-infectious 
pathogen resistance, as well as their implications in 
immune regulation [50], [51], [52].  The platelet-rich 
fibrin when combined with open-flap debridement 
produces better outcomes compared to the open 
flap debridement alone. The regenerative potential of 
platelet-rich fibrin results in better augmentation and 
regeneration of periodontal bone defects (Table 1) [23]. 
The adjunctive use of PRP together with conventional 
grafting procedures may be a beneficial treatment 
approach. However, when combined with the use of 
a regenerative technique, such as GTR, the beneficial 
effect of PRP on the treatment of intrabony defects is 
negligible (Table 1) [24].
By used of GTR with bio absorbable membranes 
in combination with Bio–oss are basically stable on a long 
term basis and the clinical and radiographical data from 
baseline and from the 1- and 5-year control wich are 
presented on this article treatment resulted in statistically 
significant clinical improvements (i.e., PPD reduction, PAL 
gain) 1 year after surgery, which were preserved during the 
following 4- year observation period. PPD had increased to 
a minor extend (0.4 mm) from the 1- to the 5-year control 
visit, but the average amount of residual PPD was not 
significantly different between the two observation periods 
(Table 1) [25].
In usage of demineralized freeze-dried bone 
allograft (DFDBA) alone with saline and PRF with DFDBA 
the 12-month results indicated that both treatment 
modalities resulted in significant changes in all clinical 
and radiographic parameters. However, the PRP/DFDBA 
group exhibited statistically significantly greater changes 
compared with the DFDBA/saline group in PD, CAL, 
REC,bone fill and defect resolution table (Table1) [26].
Treatment of furcation defects with RSV 1.2mg 
in situ gel combined with autologous PRF and porus-HA 
bone graft, results in significant improvements of clinical 
and radiographic parameters when compared with OFD 
alone. Combining RSV with PRF and HA, implies their 
synergestic effects explaining their role as a regenerative 
material in the treatment of furcation defects (Table1) [27].
PRF shows comparable results to DFDBA in 
terms of clinical parameters (Table 1) [28].
The results of this study indicate that PRF can 
improve clinical parameters associated with human 
intrabony periodontal defects, and BPBM has the ability 
to augment the effects of PRF in reducing pocket depth, 
improving clinical attachment levels and promoting defect 
fill (Table 1) [29].
Based on the results obtained from the systematic 
review by Panda et al.can be concluded that the evidence 
on the beneficial additive effect of APCs in surgical 
treatment of intrabony defects has been increasing in 
recent years (Table 1) [30].
By using Biodegradable oxidized cellulose and 
hydroxyapatite Guided tissue regeneration techniques 
have been shown to enhance new attachment formation 
with minimal post- operative recession (Table 1) [31].
PRF alone or PRF-mixed particulate autogenous 
bone increase new bone formation and has a positive 
(Table 1) [32]. The use of PRP in the alveolar socket after 
tooth extractions is certainly able to improve soft tissue 
healing and positively influence bone regeneration but this 
latter effect seems to decrease a few days after extraction 
(Table 1) [33].
 Analysis of radiographic bone density by periods 
1, 2, and 3 months after extraction of impacted mandibular 
third molars bilaterally where in one side was used PRP 
and in other side just blood clot there were favorable 
significant differences for the PRP group. At 7 days and at 
6 months, there were no statistical differences; however, 
higher means of radiographic bone density were observed 
in the PRP group (Table 1) [34].
 To compare mandibular bone regeneration 
by applying autologous bone, platelet-rich plasma and 
two biomaterials (synthetic calcium hydroxyapatite, 
and demineralized bone matrix), and thus establish the 
potential benefits of these biomaterials in the regeneration 
of post extraction alveolar bone the faster bone formation 
occurred in the groups where are used autologous bone 
and demineralized bone matrix, respectively (Table 1) [21].
 PRP, PRF, and A-PRF were able to release 
growth factors over time from their respective platelet 
formulations. Interestingly, PRP demonstrated the ability to 
release significantly higher levels of growth factors at very 
early time points whereas PRF and A-PRF had a more 
gradual release of growth factors up to a 10-day period 
(Table 1) [36].
 By compare the effect of alpha-tricalcium 
phosphate (α-TCP) cement combined with platelet-rich 
plasma (PRP) on osteogenesis, and to compare the results 
with use of PRP alone was seen that treatment with α-TCP 
cement combined with PRP does not show any significant 
difference in comparison with PRP alone (Table 1) [38].
 Beta-tricalcium phosphate alone and in 
combination with platelet-rich plasma as modalities for 
treatman of intrabony defects showed significant clinical 
radiographically improvements (Table 1) [39].
Unlike PRP, PRF contains a fibrin matrix instead 
of jellifying agents and bovine clotting factors [53]. 
It is important to note that PRF contains a number of 
cells, including platelets, leukocytes, macrophages, 
granulocytes, and neutrophils. Furthermore, PRF 
exhibits a slow and sustained release of growth factors, 
such as transforming growth factor-b1, platelet-derived 
growth factor, and vascular endothelial growth factor 
which all have been proven to promote the wound 
healing and tissue regeneration [54].
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The PRF when combined with open-flap 
debridement and combined by GTR produces better 
outcomes and better regenerative power compared 
to the OFD alone. The regenerative potential of PRF 
results in better augmentation and regeneration 
of periodontal bone defects. In addition, PRF may 
augment the regenerative potential of bone grafts. 
However, more long term and well-designed clinical 
trials are needed to ascertain the clinical efficacy of 
PRF and PRF containing bone grafts.
MIS 4MATRIX bone grafts is a new synthetic 
bone replacement product that helps in bone dental 
replacement procedures. The 4MATRIX composition 
is pure 66.6% biphasic calcium sulfate (BCS) and 
33.3% hydroxyapatite (HA) and is characterized 
by predetermined setting time and resorption rate. 
4MATRIX is the preferred augmenting-replacement 
product for a wide variety of dental bone replacement 
procedures.
Considering the bone regeneration, resorption 
rate and stabilization 4MATRIX have its advantages. 
During the administration procedure, the 4MATRIX 
BCS component remains intact in the presence of blood 
and saliva and stimulates bone growth when placed in 
contact with the bone or periosteum. 4MATRIX consists 
of two different components. BCS has a complete 
resorption rate in close connection with bone formation 
rate (4–10 weeks), while HA acts as a long-term spatial 
maintainer. A component such as HA contributes to 
the maintenance of longer-term space and provides 
higher mechanical strength and stabilization of new 
regenerated bone grafts.
Conclusion
Biomaterials being used in periodontal surgical 
treatment have the different regenerative ability. The 
combined use of biomaterials might result in a better 
clinical outcome.
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